...
机译:改变病情的抗风湿药和类固醇对人成纤维样滑膜细胞中生长抑素/血小板源性内皮细胞生长因子产生的抑制作用
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical SciencesDepartment of Molecular Neurobiology Nagoya City University Graduate School of Medical Sciences;
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical Sciences;
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical Sciences;
Department of Molecular Neurobiology Nagoya City University Graduate School of Medical Sciences;
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical Sciences;
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical Sciences;
Department of Musculoskeletal Medicine Nagoya City University Graduate School of Medical Sciences;
Department of Molecular Neurobiology Nagoya City University Graduate School of Medical Sciences;
Aurothioglucose; Disease-modifying anti-rheumatic drugs; Fibroblast-like synoviocytes; Gliostatin; Interleukin-1β; Platelet-derived endothelial cell growth factor;
机译:改变疾病的抗风湿药和类固醇对人成纤维样滑膜细胞中胶质抑制素/血小板衍生的内皮细胞生长因子产生的抑制作用。
机译:胶质抑制素/胸苷磷酸化酶调节人成纤维样滑膜细胞中血管内皮生长因子的产生。
机译:胶质抑制素/胸苷磷酸化酶调节人成纤维样滑膜细胞中的血管内皮生长因子的产生
机译:使用细菌展示方法鉴定血管内皮生长因子受体2(VEGFR2,KDR)的潜在抑制肽药物
机译:磺酰脲类和非甾体类抗炎药对人肝微粒体中Canagliflozin体外代谢的抑制作用
机译:抗风湿药对类风湿滑膜细胞血管内皮生长因子的抑制作用
机译:血小板素/血小板衍生的内皮细胞生长因子作为类风湿性关节炎的临床标志物及其在成纤维细胞样Synoviocytes中的调节